OUE Limited FY2025 Financial Analysis: Navigating Headwinds and Strategic Developments

OUE Limited, a leading real estate and healthcare group listed on SGX, reported its FY2025 results, reflecting a challenging year amidst macroeconomic headwinds and sector-specific pressures. Below, we break down the key financial metrics, business developments, and strategic actions disclosed in the company’s annual press release.

Key Financial Metrics & Year-on-Year Performance

Segment Analysis & Exceptional Items

• Real Estate: Revenue fell by 7.7% YoY, largely due to the divestment of Lippo Plaza Shanghai and lower hospitality revenue following a high base from concert-driven tourism and changes in visa-free arrangements.
• Healthcare: Segment revenue was resilient, up 0.3% YoY, supported by strong performances in Singapore clinics and new acquisitions, offset by closure of PRC pharmaceutical business and unfavorable FX movements affecting First REIT.
• Others: Revenue grew 9.8% YoY, driven by new dining outlets and expanded concepts.
• Exceptional Expenses: The loss was mainly due to non-cash items: share of losses in equity-accounted investees, impairment losses related to Gemdale Properties (S\$20m), and fair value changes in investment properties. The divestment of Lippo Plaza Shanghai eliminated a recurring fair value loss.

Dividends

• Final tax-exempt dividend: 1.0 Singapore cent per share for FY2025.
• Total dividend for FY2025: 2.0 Singapore cents per share (including interim dividend).

Strategic & Corporate Actions

• OUE REIT: Proactive capital management with a S\$600m green loan refinancing (OUE Bayfront), S\$225m revolving credit, S\$5m bank guarantee, and a S\$500m Commercial Paper Programme. Issued S\$150m 7-year green notes at a record-low 2.75% coupon, with 80% institutional allocation.
• Asset Acquisition: OUE REIT acquired a 19.9% stake in Salesforce Tower, Sydney (A\$357.2m property value; A\$195.5m consideration), enhancing portfolio quality and geographic diversity.
• Healthcare Expansion: OUE increased its stake in OUE Healthcare Limited to 89.68%. Hospitals in Greater China made clinical advancements, and Healthway Medical Group marked its 35th anniversary with continued growth and refinancing for expansion.
• Divestments: First REIT divested Imperial Aryaduta Hotel & Country Club, recycling capital and sharpening portfolio focus.
• Dining Portfolio: Four new dining establishments launched, with Chatterbox expanding internationally (Macau, Manila, Tokyo).

Balance Sheet & Liquidity

• Net gearing: 53.8% as at 31 December 2025.
• Liquidity: Management asserts sufficient liquidity for debt obligations and operations.

Business Review & Outlook

• Zero-Energy Hotel Project: Groundbreaking partnership with Tokyo Century Corporation for Singapore’s first zero-energy hotel at Changi Airport. Green loan facility of S\$130m secured.
• Healthcare Innovation: Expansion of specialist clinics, enhanced hospital capabilities, and new services in China and Singapore.
• Portfolio Resilience: OUE REIT and healthcare arms remain disciplined in capital management and expansion, positioning for long-term growth.

Chairman’s Statement

No explicit Chairman’s statement was included in the report. However, the overall tone is cautiously optimistic, highlighting resilience in liquidity, proactive capital management, and ongoing strategic initiatives despite reporting losses.

Conclusion & Investor Recommendations

Overall Assessment: OUE Limited’s FY2025 results show narrowed losses and robust liquidity amid sectoral and economic challenges. The group’s proactive capital management, strategic asset recycling, and expansion in both real estate and healthcare signal a commitment to long-term portfolio strengthening. However, persistent losses, driven by non-cash impairment and equity-accounted investee losses, highlight ongoing risks in certain segments, particularly China property.

• If currently holding OUE stock: Investors may consider holding their position, given the company’s strong liquidity, ongoing portfolio diversification, and disciplined capital management. The declared dividend and strategic investments could support long-term recovery, but risks remain, particularly from associated companies and macro headwinds.
• If not currently holding OUE stock: Caution is warranted. While OUE’s initiatives in sustainability, healthcare expansion, and asset management are promising, the company remains loss-making. Potential investors should closely monitor recovery in real estate and China exposures, and await clearer signs of earnings turnaround before initiating new positions.

Disclaimer: This analysis is based solely on information disclosed in OUE Limited’s FY2025 press release and does not constitute financial advice. Investors should do their own due diligence and consult professional advisors before making investment decisions.

View OUE Historical chart here